Strona 21 - Najlepsi lekarze wykonujący TK (tomografię komputerową) – TOP 597 lekarzy

Zainteresowania medyczne:

• Operacje guzów mózgu, móżdżku, kręgosłupa i rdzenia kręgowego u dorosłych i dzieci

• Operacje neurochirurgiczne dziecięce (wodogłowie, przywiązanie rdzenia kręgowego, diastematomielia, przepuklina mózgowa, przepuklina oponowo-rdzeniowa, wycięcie zatoki skórnej, kraniosynostoza)

• Chirurgia kręgosłupa (przepuklina dyskowa odcinka lędźwiowego i szyjnego, spondyloliza, zwężenie kanału kręgowego, stabilizacja złamań kręgosłupa, operacje wertebroplastyki-kifoplastyki, operacje kifozy)

• Chirurgia głębokiej stymulacji mózgu w leczeniu choroby Parkinsona, drżenia samoistnego i dystonii

• Chirurgia stymulacji nerwu błędnego (chirurgia padaczki) • Chirurgia stymulacji rdzenia kręgowego (stymulator bólu rdzenia kręgowego)

• Operacje neuralgii nerwu trójdzielnego i kurczu połowiczego twarzy

• Zabieg wszczepienia pompy baklofenowej (w przypadku ciężkiej spastyczności)

• Operacje tętniaków, tętniczo-żylnych naczyń krwionośnych i jamistych naczyń krwionośnych

Dr. Mustafa Kilic is a skilled neurosurgeon with expertise in neuromodulation. He performs Deep Brain Stimulation, Spinal Cord Stimulation, and Sacral Nerve Stimulation. Dr. Kilic manages all stages of patient care, from preoperative evaluation to postoperative follow-up. He focuses on achieving the best possible outcomes for his patients.

Dr. Kilic is an Associate Professor at Istinye University. He is active in neurosurgery research and education. As a member of the Turkish Neurosurgical Society, he has completed many advanced neuromodulation procedures. His work has led to high patient satisfaction and strong results in complex neurological cases.

Prof. Çağatay Öztürk jest doświadczonym chirurgiem ortopedą i kręgosłupa, specjalizującym się w skoliozie i chirurgii kręgosłupa. Posiada dyplom lekarza Uniwersytetu Hacettepe oraz specjalizację z ortopedii i traumatologii Uniwersytetu Uludağ. Jest kierownikiem Oddziału Chirurgii Kręgosłupa w Szpitalu Liv i członkiem kilku organizacji zawodowych. Opublikował ponad 100 artykułów w międzynarodowych edycjach.

Obszar zainteresowań i działalności medycznej

Neurochirurgia funkcjonalna (choroba Parkinsona, głęboka stymulacja mózgu)

Guzy mózgu i rdzenia kręgowego

Choroby zwyrodnieniowe kręgosłupa Edukacja

Wydział Lekarski Uniwersytetu Cerrahpaşa w Stambule

Uniwersytet Trakya Wydział Medycyny Chirurgia Mózgu i Nerwów

Doświadczenie

Ankara Gülhane Wojskowa Akademia Medyczna Chirurgia Mózgu i Nerwów

Szpital Państwowy Osmaniye

Szpital państwowy w Bolu

Prywatny szpital niemiecki Taksim

Szpital szkoleniowy i badawczy Taksim

Uniwersytet w Stambule Wydział Medycyny Chirurgia Mózgu i Nerwów

Szpital Liv Ulus

Członkostwa

Tureckie Towarzystwo Neurochirurgii

Tureckie Stowarzyszenie Medyczne

Dr. Adem Topaloglu is a general surgeon with expertise in laparoscopic oncology. He focuses on colon and rectal cancers. He graduated from Karadeniz Technical University Faculty of Medicine in 1998. He completed his general surgery training at Eskişehir Osmangazi University in 2009.

Dr. Topaloglu performs advanced minimally invasive surgeries. His procedures include laparoscopic gastric, colon, and rectal cancer surgeries, as well as anti-reflux surgery, hernia repairs, appendectomy, and cholecystectomy. He is also experienced in endocrine and gastroenterological surgeries. In addition, he performs bariatric procedures such as gastric sleeve, bypass, and balloon interventions.

Dr. Topaloglu holds certifications in obesity, hiatal, and inguinal hernia surgeries. He is skilled in gastroscopy and colonoscopy. His expertise helps improve patient outcomes and surgical success rates.

Dr. Jaydeep Palep is a bariatric and upper GI surgeon with 17 years of experience. He specializes in minimally invasive and robotic weight loss surgeries. Dr. Palep is one of the first surgeons in India trained in Banded Bypass, Banded Sleeve Gastrectomy, and Mini Gastric Bypass. He has also received advanced training in Robotic GI Surgery in Italy and the USA.

Dr. Palep’s bariatric practice is certified as a Center of Excellence by the International Excellence Foundation (IEF). His practice has a morbidity rate of just 1%, which matches global standards. More than 90% of his diabetic patients stop using insulin and oral medications after surgery. He has published many articles in international journals and is invited to speak at conferences around the world.

Dr. Anna Dabkowska is a dentist who specializes in conservative dentistry, endodontics, periodontology, prosthetics, and implant prosthetics. She graduated from the Faculty of Dentistry at the Medical University of Warsaw. She has expanded her skills through many trainings in Poland and abroad.

Dr. Dabkowska is known for her work in aesthetic dentistry. She performs smile reconstruction using veneers, crowns, and bridges. She also treats temporomandibular joint disorders. She is currently completing advanced training in gnatology and occlusion. Dr. Dabkowska uses modern aesthetic medicine methods, including botulinum toxin and platelet-rich plasma therapies, in her dental practice.

Dr Somkiat Aimplee jest certyfikowanym specjalistą American Academy of Cosmetic Dentistry i posiada Master Certification by Digital Smile Design. Ukończył Wydział Stomatologii na Srinakharintharawirote University (Tajlandia) i ukończył edukację w zakresie protetyki i stomatologii estetycznej w Dental College of Georgia na Augusta University (USA).

Areas of Interests

• Neuro-oncological surgery
• Spinal Surgery
• Pediatric Neurosurgery
• Peripheral Nerve Surgery
• Functional Neurosurgery and Algology

Education:

• Istanbul University, Faculty of Medicine
• Istanbul Okmeydani Training and Research Hospital

Experience:

• Liv Hospital Ulus
• Sisli Kolan Hospital
• Prof.Dr.Cemil Taşcıoğlu City Hospital
• Ardahan State Hospital

Research:

• Tumor markers and other laboratory findings in brain tumors
• Antiepileptic drugs in operated brain tumors
• Cervical corpectomy techniques
• Pre-emptive analgesia in spine surgeries

Publications:

• Uysal E, Cine HS, Yavuz AY, Cal MA. Impact of subventricular zone interaction on clinical outcomes in patients with intracerebral hematoma. Experimental Biomedical Research, 2024;7(3): 117–126. https://doi.org/10.30714/j-ebr.2024.215
• Çal MA, Yangı K. A Single-center Study Comparing Volumetric and Morphometric Measurements of Chiari Malformation in the Turkish Population. Eur Arc Med Res.2024 Mar;40(1):50-56. doi:10.4274/eamr.galenos.2024.24892.
• Avcı İ, Başkurt O, Şeker S, Kurtuluş Y, Çal MA. Rapid Recurrence of Glioblastoma After 12 Days Despite Gross Total Resection. Eur Arc Med Res.2024 Mar;40(1):62-65. doi:10.4274/eamr.galenos.2024.48615.
• Play MA. The relationship between vertebral compression rates and systemic inflammatory scores in osteoporotic vertebral fractures. Eur Rev Med Pharmacol Sci. 2024;28(3):959-968. doi:10.26355/eurrev_202402_35333
• Çal MA, Gök H. Retrospective Evaluation of the Effect of Surgery and CyberKnife on Recurrence and Neurological Deficits in Cases Diagnosed as Vestibular Schwannoma. Haydarpasa Numune Med J.2023;63 (1), 62 ‑67.doi:10.14744/hnhj.2022.45712
• Uysal E, Çal MA, Cine HS. The use of vancomycin powder in the compound depressed skull fractures. Clin Neurol Neurosurg. 2023;225:107570. doi:10.1016/j.clineuro.2022.107570
• Gök H, Şeker S, Peker HO, Çal MA, Altay T, Çelik S. A rare case report: Cervical subcutaneous and mediastinal emphysema due to mastoid fracture. A rare case report: Cervical subcutaneous and mediastinal emphysema due to mastoid fracture. Ulus Travma Emergency Surgery Journal . 2020;26(2):328 ‑330. doi:10.14744/tjtes.2019.02828
• Çınar N,Karaoğlan A,Midi A,Çal MA,Kelten B,Çakmak MA,Şahin Ş. Neuroprotective effect of ziprasidone: Preliminary results compared to haloperidol. J. Exp. Clin. Med ., 2014; 31:71 ‑75. doi : 10.5835/jecm.omu.31.02.002
• Karaoglan A, Cal MA, Orki A, Arpaozu BM, Colak A. Pneumorrhachis associated with bronchial asthma , subcutaneous emphysema and pneumomediastinum . Turkish Neurosurg . 2011;21(4):666 ‑668.
• Kelten B, Karaoğlan A, Cal MA, Akdemir O, Karancı T. Human immunodeficiency Bilateral epidural puncture in a patient infected with the virus Hematoma : Case report [ Bilateral epidural hematoma in a patient with Human immunodeficiency virus infection : a case report ]. Ulus Trauma Emergency Surgery Journal . 2013;19(3):267 ‑270. doi: 10.5505 /tjtes.2013.49799
• Karaoglan A, Akdemir O, Cinar N, et al. Correlation between leptin and pro- ‑inflammatory cytokines in cortical contusion injury model. Ulus Trauma Emergency Surgery Journal . 2011;17(4):298 ‑302. doi: 10.5505 /tjtes.2011.69077
• Cal MA, Kelten B, Akbas A, Akdemir O, Karaoglan A. Coexistence of spinal lipoma, ependymal cyst and dermoid cyst in neighboring localizations in context medullaris : A case report . HealthMed . 2013; 7(12):3227
• Canpolat A, Duman H, Akbaş A, Çal MA, Akdemir AO. Diffuse dysphagia and myeloradiculopathy presenting idiopathic skeletal hyperosteosis ( Forestier Disease). TC Maltepe University Medical Faculty Journal.2012;4(2),14 ‑17
• Karaoglan A, Kelten B,Akdemir AO,Çal MA. Lumbar spine presenting with radiculopathy spinal Chondroma : Case report. TC Maltepe University Medical Faculty Journal. 2011;3(3),28 ‑30
•  
• Istanbul Medical Chamber
• Turkish Neurosurgery Association
   

Areas of Interests

• Breast cancer
• Lung cancer
• Colorectal cancers
• Gynecological and urogenital cancers
• Molecular Oncology

Education:

• Kızıltepe Anatolian High School 2001
• Dicle University Faculty of Medicine 2007
• Istanbul Medeniyet University Göztepe Training and Research Hospital 2014
• Kartal City Hospital 2021
• Associate Professor of Medical Oncology 2023

Experience:

• Liv Hospital Ulus
• Adıyaman University Training and Research Hospital
• Istanbul Umraniye Training and Research Hospital
• Istanbul Umraniye Training and Research Hospital

Research:

• Phase II, Randomized, Open-Label, Multicenter Study to Comparatively Evaluate the Efficacy and Safety of GDC-9545 and Physician-Preferred Endocrine Monotherapy in Previously Treated, Estrogen Receptor Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer Patients, Other ( International), Dr. Murat Ayhan
• Phase III, Randomized, Evaluating the Efficacy and Safety of Palbociclib and Fulvestrant with Gdc-0077 Compared with Placebo in Patients with Pik3ca-Mutant, Hormone Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer. Double Blind, Placebo Controlled Study, Other (International), Dr. Murat Ayhan
• Randomized, Multicenter, Phase Ib/III Study Evaluating the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Atezolizumab Compared to Intravenous Atezolizumab in Patients with Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung Cancer, Other (International) Dr. Murat Ayhan
• Randomized, Controlled, Multicenter, Open-Label Study Including Observation Follow-Up for PSMA-PET-Negative Patients, Investigating the Efficacy and Safety of Addition of Apalutamide to Radiotherapy and LHRH Agonist in PSMA-PET-Positive High-Risk Hormone-Sensitive Prostate Cancer Patients, Other (International) Dr. Murat Ayhan
• Biomarker Study to Identify Patients with Advanced Stage Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations-42756493BLC0002, Other (International), Dr. Murat Ayhan
• Publications:
• Ayhan M, Turan N, Köstek O, et all. Does the efficacy of regorafenib differ in chemotherapy refractory metastatic colorectal cancer patients who had mucinous pathology compared to those who had non-mucinous pathology? Curr Probl Cancer. 2021 Jun;45(3):100670. doi: 10.1016/j.currproblcancer.2020.100670.
• Ayhan M, Odabas H, Turan N, et all. Factors affecting the mortality rate of patients with cancer hospitalized with COVID-19: a single center's experience. J Chemother. 2021 Nov;33(7):499-508. doi: 10.1080/1120009X.2021.1923153.
• Ayhan M, Laçin Ş, Özyükseler DT, et all. Does systemic anti-tumor therapy increase COVID-19 risk in patients with cancer? J Oncol Pharm Pract. 2021 Sep;27(6):1461-1467. doi: 10.1177/10781552211015762.
• Ayhan M, Abamor E, Coban Kokten S, et al. Value of FDG PET/CT in Predicting Pathologic Complete Response After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer. EJMI 2022;6(2):165–175.
• Ayhan M, Terzioglu K. Experience With Rapid Drug Desensitization With Chemotherapeutics; A SingleCentre Retrospective Study. EJMI 2021;5(3):380–387.
• Doğan A, AYHAN M. Survival analysis of patients with triple-negative breast cancer: a single-center experience. Journal of Oncological Sciences, 8(2), 94-99., Doi: 10.37047/jos.2022-89749
• Terzioğlu K, Ayhan M. Comparative Assessment of Platinum Salts and Taxane Group Hypersensitivity Reactions, The Role of Skin Tests in Diagnosis? J Oncol Pharm Pract. 2021 Nov 30:10781552211050084. doi: 10.1177/10781552211050084.
• Tacar SY, Selcukbiricik F, Yilmaz M, Erturk K, Murat Sarici A, Gulturk I, Ayhan M, Tural D. Nivolumab for metastatic uveal melanoma: a multicenter, retrospective study. Melanoma Res. 2021 Oct 1;31(5):449-455. doi: 10.1097/CMR.0000000000000744.
• Özyurt E, Özçelik S, Sürmeli H, Çelik M, Ayhan M, Özçelik M. Side effects of immune-checkpoint inhibitors: Can multiple side effects be seen in a patient? J Oncol Pharm Pract. 2022 Mar;28(2):462-465. doi: 10.1177/10781552211038136.
• Dülgar Ö, Öven BB, Atcı MM, Arıkan R, Ay S, Ayhan M, Selvi O, Ozyukseler DT, Bayram E, Özcan E, Yasin Aİ, Gümüş M. Is the benefit of using adjuvant capecitabine in patients with residual triple-negative breast cancer related to pathological response to neoadjuvant chemotherapy? Expert Rev Anticancer Ther. 2022 Jul;22(7):773-780. doi: 10.1080/14737140.2022.2076670.
• Hizal M, Bilgin B, Paksoy N, Ayhan M, et all. The real-life efficacy and safety of osimertinib in pretreated advanced non-small cell lung cancer patients with T790M mutation: a Turkish Oncology Group Study. J Cancer Res Clin Oncol. 2022 Jun;148(6):1501-1508. doi: 10.1007/s00432-021-03748-7.
• Volume I, Kucukarda A, Atcı MM, Ayhan M, et all. Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world study. Tumori. 2022 Feb;108(1):19-25. doi: 10.1177/03008916211037739.
• Dogan I, Ayhan M, Gurbuz M, et all. The frequency and prognostic significance of ABO/Rh blood groups in male breast cancer patients: A multicenter study. Medicine (Baltimore). 2022 Sep 2;101(35):e30147. doi: 10.1097/MD.0000000000030147.
• Ozcelik M, Oyman A, Cil I, Duzgun O, Ozkan OF, Ayhan M. Cytoreductive Surgery versus Systemic Chemotherapy alone in Isolated Peritoneal Carcinomatosis of Colorectal Origin. J Coll Physicians Surg Pak. 2021 Nov;31(11):1308-1313. doi: 10.29271/jcpsp.2021.11.1308.
• Başoğlu T, Sakin A, Erol C, Ayhan M, et all. Real life experienceof patients with locally advanced gastric and gastroesophageal junction adenocarcinoma treated with neoadjuvant chemotherapy: a Turkish oncology group study. J Chemother. 2022 May 17:1-8. doi: 10.1080/1120009X.2022.2073159.
• Özdemir Ö, Zengel B, Yildiz Y, Ayhan M, et all. The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study. Anticancer Drugs. 2022 Aug 1;33(7):663-670. doi: 10.1097/CAD.0000000000001310.
• Hizal M, Bilgin B, Paksoy N, Ayhan M, et all. The percentage of ALK-positive cells and the efficacy of first-line alectinib in advanced non-small cell lung cancer: is it a novel factor for stratification? (Turkish Oncology Group Study). J Cancer Res Clin Oncol. 2022 Sep 1. doi: 10.1007/s00432-022-04252-2.
• Hizal M, Bilgin B, Paksoy N, Ayhan M, et all. Real-world data on efficacy and safety of first-line alectinib treatment in advanced-stage, ALK-positive non-small-cell lung cancer patients: a Turkish Oncology Group study. Future Oncol. 2022 Jul;18(23):2573-2582. doi: 10.2217/fon-2022-0083.
• Topcu A, Atci MM, Secmeler S, Besiroglu M, Ayhan M, Ozkan M, Bozkurt O, Urakci Z, Ay S, Geredeli C, Yasin AI, Turk HM. Efficacy of trastuzumab and potential risk factors on survival in patients with HER2-positive metastatic gastric cancer. Future Oncol. 2021 Nov;17(31):4157-4169. doi: 10.2217/fon-2021-0398.
• Bilgin B, Sendur MAN, Yucel S, Ayhan M, et all. Real-life comparison of the afatinib and first-generation tyrosine kinase inhibitors in nonsmall cell lung cancer harboring EGFR exon 19 deletion: a Turk Oncology Group (TOG) study. J Cancer Res Clin Oncol. 2021 Jul;147(7):2145-2152. doi: 10.1007/s00432-020-03501-6.
• Atci MM, Akagunduz B, Demir M, Arikan R, Ay S, Ozer M, Ayhan M, Cil I, Demir N, Ozyurt N, Karakaya G, Cevik GT, Onder AH, Selvi O, Sakin A. The impact of adjuvant oxaliplatin and tumor sidedness on the overall survival of stage IIB colon cancer patients: a multicentre study. J Chemother. 2023 Feb;35(1):19-28. doi: 10.1080/1120009X.2022.2040770.
• Tataroglu Ozyukseler D, Ay S, Turan M, Alkan G, Ayhan M, Surmeli H, et al. The Systemic Inflammation Response Index as a Prognostic Marker in Advanced Pancreatic Cancer. EJMI 2022;6(3):367–373.
• Yıldız F, Ayhan M, Demir H, et all. Comparing the efficacy of cabazitaxel in secondline and third-Line treatment of metastatic castration-resistant prostate cancer: a multi-center experience from Turkey. International Journal of Contemporary Medical Research, 7(9), 112-116.,Doi: 10.21276/ijcmr.2020.7.9.30
• Terzioğlu K, Ayhan M. Distribution of allergens detected on patch tests of patients with allergic contact dermatitis and investigation of their atopic background. Annals of Medical Research, 29(5), 422-426., doi: 10.5455/annalsmedres.2021.07.490
• Arikan R, Atci MM, Ay S, Ayhan M, et all Prognostic significance of mucinous histology in left sided metastatic colorectal cancers with wild type RAS and evaluation of backbone chemotherapy regimens. Oncol Lett. 2023 Apr 5;25(5):208. doi: 10.3892/ol.2023.13795.
• Almuradova E, Yalcin S, Arıkan R, Ayhan M, Demir H, Cevik GT, Karaca M, Petekkaya I, Karabulut B. Survival of Patients With Metastatic Rectum Cancer Who Underwent Metastasectomy Following Conversion Chemotherapy Sans Pelvic Radiotherapy: A Turkish Oncology Group Study. Cureus 2023 May 17;15(5):e39119. doi: 10.7759/cureus.39119.
• Topcu A, Besiroglu M, Atci MM, Ayhan M, et all. Second-line Therapy after Trastuzumab Failure in HER2-Positive Metastatic Gastric Cancer: A Real-life Data. EJMI 2023;7(2):153–161. DOI: 10.14744/ejmi.2023.22720
• Book Writing:
• Drug interactions and side effects of targeted agents, Section name: (Small molecule tyrosine kinase inhibitors; ROS-1 targeted therapies (Crizotinib, Seritinib)) (2021)., AYHAN MURAT, Turkish Clinics Journal of Medical Sciences, Editor: Mehmet Aliustaoglu, Publishing number:1, Number of Pages 92, ISBN:978-625-401- 466-6, Turkish
• Approach to gastrointestinal stromal tumors and neuroendocrine tumors, Department name: (Medical approach in primary non-gastrointestinal neuroendocrine tumors) (2020)., AYHAN MURAT, Akademisyen Yayınevi, Editor: Anılır Ender, Number of editions: 1, Number of Pages 382, ISBN: 9786052585719, Turkish
• Internal medicine emergencies, Department name: (Oncological emergencies) (2022)., YILDIRIM SEDAT, AYHAN MURAT, Efe Academic Publishing, Editor: Serdar Olt, Number of editions: 1, Number of Pages 232, ISBN: 978-625-8324-66- 2, Turkish
• Physicians' chemotherapy cancer drug manual 2020, Section name: (Common chemotherapy regimens in clinical practice) (2022)., SÜMBÜL AHMET TANER, ALKAN ALI, AKSOY ASUDE, AYHAN MURAT, et all, Türkiye Klinikleri Journal of Medical Sciences, Editor: EDWAR CHU, VINCENT T. DEVITA, SAADDETIN KILIÇKAP, CEMIL BILIR, SELÇUK SEBER, Number of editions: 1, Number of pages 772, ISBN: 978-625-401-290- 7, Turkish (Book Translation)

Edukacja:

• Wykształcenie wyższe (6 lat): Wydział Lekarski Uniwersytetu Marmara, 2001
• Specjalizacja w medycynie: Uniwersytet w Stambule, Wydział Lekarski w Stambule, 2007
  

Doświadczenie:

• Wydział Lekarski, Uniwersytet w Rostocku, Katedra Chirurgii Serca - Asystent Badawczy, sierpień 2007 - sierpień 2008
• Szpital Specjalistyczny im. Króla Faisala i Ośrodek Badawczy, Instytut Serca Króla Faisala – stypendysta, sierpień 2008 r. – październik 2008 r.
• Prywatny szpital Göztepe Şafak, październik 2008 - kwiecień 2009
• Prywatny szpital Esnaf, maj 2009 - marzec 2010
• Szpital Państwowy Düzce Atatürk, marzec 2010 - wrzesień 2011
• Prywatny Szpital Centrum Medycznego Anadolu, październik 2011 - czerwiec 2013
• Uniwersytet w Stambule Wydział Lekarski w Stambule, lipiec 2013 - grudzień 2018
• Uniwersytet Medipol w Stambule, Wydział Lekarski, styczeń 2019 - kwiecień 2023
• Wydział Lekarski Uniwersytetu Biruni, kwiecień 2023 r. – obecnie
• Profesor: 18 grudnia 2020 r.
• Profesor nadzwyczajny: 16 kwietnia 2015 r. – 18 grudnia 2020 r.
• Lekarz specjalista: listopad 2009- 16 kwietnia 2015
• Asystent badawczy: czerwiec 2002 - lipiec 2007
• Wydział Lekarski: Uniwersytet Marmara - angielski (1995-2001) [Ocena dyplomu: 75/100 ] - Wpisany do Światowego Katalogu Szkół Medycznych.

Nagrody:

Nagroda za drugą najlepszą prezentację ustną: Didem Melis Öztaş, Mert Meriç, Metin Onur Beyaz, Mehmet Akif Onalan, Shiraslan Bakhshaliyev, Kıvılcım Sönmez, Kerem Oter, Sedat Ziyade, Beyhan Ömer, Ufuk Alpagut, Murat Uğurlucan. Badanie wpływu erytropoetyny na poziom komórek macierzystych w tkance sercowo-naczyniowej u szczurów z cukrzycą. 19. Krajowy Kongres Chirurgii Naczyniowej i Wewnątrznaczyniowej, Kyrenia, Cypr, 26-29 października 2019 r.

Areas of Interests

• General Neurology
• Clinical Neurophysiological examinations (Electromyography, evoked potentials, electroencephalography, polysomnography)
• Peripheral Nervous System Diseases
• Muscle diseases
• Epilepsy
• Headache
• Sleep and sleep disorders
• Migraine botox and botulinum A toxin applications

Education:

• 1980-1985 Atatürk Elementary School
• 1985-1988 Anamur High School
• 1988-1991 Anamur High School
• 1991-1998 Marmara University Faculty of Medicine in English
• 2000- 2004 PTT Education and Research Hospital Neurology Clinic (Medical Specialization Student)
• 2007-2010 Istanbul University Health Sciences Experimental Medicine Research Institute Electroneurophysiology Master's Program
• 2012- Clinical Neurophysiology Sub-branch Specialist

Experiences:

• September 2023-Currently Haliç University Faculty of Medicine, Faculty Member
• January 2023-Currently Hisar Intercontinental Hospital, Department of Neurology
• 2014- August 2023 Bilgi University Health Sciences Vocational School Electroneurophysiology Department, Faculty Member
• 2019- 2022 Ataşehir Private Avicenna Hospital, Neurology Department
• 2009-2018 Fatih Sultan Mehmet Education and Research Hospital Neurophysiology Laboratory (Specialist Doctor)
• 2007-2010 Istanbul University Health Sciences Experimental Medicine Research Institute Electroneurophysiology Master's Program
• 2005-2006 Istanbul University Istanbul Faculty of Medicine Department of Neurology Electrodiagnostics Department EMG Laboratory
• 2000-2004 PTT Education and Research Hospital Neurology Clinic (Specialist Student in Medicine)

Dr. Cengiz Sen is an Orthopedics and Traumatology specialist. He has expertise in revision arthroplasty, degenerative joint disease, congenital limb deformities, and pediatric orthopedic disorders. Dr. Sen is skilled in limb lengthening, pseudoarthrosis surgery, and managing periprosthetic infections. He is also a pioneer in using stem cell therapy for orthopedic conditions.

Dr. Sen has published many articles, especially on total knee replacement and infected nonunion. He is a professor at Istanbul University Faculty of Medicine. He has received the AOTT Oral Presentation Award for his academic and clinical achievements.

Dr. Hilmi Apak is a respected pediatric hematology-oncology specialist with more than 21 years of experience. He is trained in pediatric oncology. Dr. Apak has led advanced treatments, including bone marrow transplantation, leukemia chemotherapy, and CAR T-cell therapy.

He has published 75 international medical articles, showing his strong contribution to pediatric oncology research. Dr. Apak has worked as assistant editor for the Turkish Pediatrics Archives Periodical. He has also held important academic and leadership positions, such as Head of Pediatric Hematology-Oncology at Istanbul University-Cerrahpaşa.

Areas of Interests

• Demyelinating Diseases and MS
• Peripheral Neuropathy and Motor Neuron Disease (ALS)
• Neuromuscular Junction Diseases (MG)

Education 

• M.Sc. Faculty of Medicine, Ondokuz Mayıs University  1990
• Specialization in Medicine  Neurology,  Ankara Training and Research Hospital 1997
• Minor Specialization  Clinical Neurophysiology, Medical Specialization Board 2011

Experience

• Doctor MoH Kastamonu and Samsun Health Center No. 7 1990-1992
• Dr. Res.Assist. Ankara Training and Research Hospital Neurology Clinic 1992-1997
• Assoc. Dr. Abant İzzet Baysal University Düzce Faculty of Medicine 1999-2006
• Assoc.Dr. Duzce University Faculty of Medicine 2007-2011
• Prof.Dr  Duzce University Faculty of Medicine  2011-

Edukacja

• Wydział Lekarski: Uniwersytet Trakya, 1982-1988
• Rezydentura z zakresu radioterapii onkologicznej: Szpital badawczy i szkoleniowy Şişli Etfal, 1994-1998
• Rezydentura z radioterapii onkologicznej: Szpital Princess Margaret w Toronto, 1996
• Tytuł magistra fitoterapii: Wydział Farmacji Uniwersytetu w Stambule, 2017-2018

Doświadczenie

• Profesor, Kierownik Katedry: Wydział Nauk o Zdrowiu Uniwersytetu Bursa Wydział Lekarski, Katedra Radioterapii Onkologicznej, 2021-2024
• Profesor, Kierownik Katedry: Wydział Lekarski Uniwersytetu Nauk o Zdrowiu w Izmirze, Katedra Radioterapii Onkologicznej, 2021-2024
• Profesor: Katedra Radioterapii Onkologicznej, Wydział Lekarski Uniwersytetu Nauk o Zdrowiu w Stambule Hamidiye, 2021-2024
• Wykładowca Gelisim University SMYO, 2013-2020

Zainteresowania medyczne

• Rak piersi / Radioterapia śródoperacyjna
• Nowotwory ginekologiczne / Zastosowania brachyterapii
• Guzy układu pokarmowego
• Certyfikat i aplikacja na raka prostaty / hydrożelowe wiosło kosmiczne
• Rak płuc
• Guzy mózgu
• Nowotwory głowy i szyi

Obszary zainteresowań

• Dziecięca chirurgia rekonstrukcyjna układu moczowo-płciowego
• Hipospadia
• Obrzezanie
• Chirurgia onkologiczna
• Wrodzone nieprawidłowości górnego i dolnego układu moczowego
• Chirurgia noworodków
• Dziecięca chirurgia brzuszna

Edukacja
 

• 1997 - Uniwersytet 19 Mayıs
• 1998 - Krajowy Kongres Chirurgii Dziecięcej, Najlepsze badanie naukowe
• 2001 - Uniwersytet Kocaeli
• 2007 - Rząd Kosowa
• 2009 - Uniwersytet Yeditepe
• 2009 - Kongres Arabii Saudyjskiej, Najlepsze badanie kliniczne

Doświadczenie
 

• Liceum FMV Işık
• Wydział Medyczny Uniwersytetu Stambulskiego Cerrahpaşa
• Uniwersytet Ondokuz Mayıs
• Szpital Dziecięcy Zeynep Kamil
• Wydział Medyczny Uniwersytetu Kocaeli
• UT Southwestern Medical Center, pediatryczna urologia, Dallas, USA
• Centrum Medyczne Uniwersytetu Ege, pediatryczna urologia
• Uniwersytet Yeditepe

Prof. dr Selami Sozubir jest autorem 65 publikacji naukowych, które uzyskały ponad 11 000 odczytów i niemal 1 000 cytowań, co odzwierciedla jego istotny wkład w rozwój chirurgii dziecięcej i urologii.